Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors
João Lobo(Universidade do Porto), Cármen Jerónimo(Universidade do Porto), Catarina Guimarães‐Teixeira(Instituto Português de Oncologia Francisco Gentil), Vera Constâncio, Vera Miranda‐Gonçalves(Instituto Português de Oncologia Francisco Gentil), Joaquina Maurício(Instituto Português de Oncologia Francisco Gentil), Rui Henrique(Universidade do Porto), Mariana Cantante(Instituto Português de Oncologia Francisco Gentil), Laura Pistoni(University of Pisa), Rita de Cássia Avellaneda Guimarães(Universidade Federal de Mato Grosso do Sul), José Pedro Sequeira(Instituto Português de Oncologia Francisco Gentil), Leendert H. J. Looijenga(University Medical Center Utrecht), Pedro Leite‐Silva(Instituto Português de Oncologia Francisco Gentil), Isaac Braga(Instituto Português de Oncologia Francisco Gentil)
Cited by 23
Related Papers
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Intragenic ERBB2 kinase mutations in tumours
|Nature|2004|790
Morphological and Immunohistochemical Differences between Gonadal Maturation Delay and Early Germ Cell Neoplasia in Patients with Undervirilization Syndromes
|The Journal of Clinical Endocrinology & Metabolism|2005|196
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167